Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model (Q42274901)

From Wikidata

Jump to navigation Jump to search

scientific article published on 23 August 2013

Language	Label	Description	Also known as
English	Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model	scientific article published on 23 August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

0 references

1 reference

based on heuristic

inferred from title

5-fluorocytosine

1 reference

based on heuristic

inferred from title

author name string

T T Huang

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

J Hlavaty

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

D Ostertag

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

F L Espinoza

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

B Martin

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

H Petznek

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

M Rodriguez-Aguirre

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

C E Ibañez

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

N Kasahara

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

W Gunzburg

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

H E Gruber

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

D Pertschuk

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

D J Jolly

13

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

J M Robbins

14

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

23 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

544-551

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Glioblastoma survival in the United States before and during the temozolomide era.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Improved survival time trends for glioblastoma using the SEER 17 population-based registries

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Adult glioblastoma multiforme survival in the temozolomide era: A population‐based analysis of Surveillance, Epidemiology, and End Results registries

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

5-Fluorouracil and 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) Followed by Hydroxyurea, Misonidazole, and Irradiation for Brain Stem Gliomas: A Pilot Study of the Brain Tumor Research Center and the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

5-Fluorouracil: mechanisms of resistance and reversal strategies

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

21 January 2018

The safety of temozolomide in the treatment of malignancies

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of 5-fluorouracil plus folinic acid in malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of 5-fluorouracil-2- 14 C and its metabolites in a murine glioma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2013.51

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2013.51

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42274901&oldid=2205193763"